Harnessing Remote Neuromodulation: Migraine Relief Unveiled
- MigraineMind
- Nov 28, 2025
- 1 min read
Research Summary
A recent review in the journal Current Pain and Headache Reports explores the mechanism of action behind Remote Electrical Neuromodulation (REN) for treating migraines and other idiopathic pain conditions. REN, a non-drug therapy, uses a wearable device called Nerivio, cleared by the FDA for patients aged 8 and older and CE marked for those 12 and above. The review explains how REN targets deficiencies in conditioned pain modulation (CPM), a brain mechanism that helps inhibit pain. By stimulating specific nerve fibers, REN enhances CPM and boosts natural pain inhibition through norepinephrine and serotonin release, offering potential relief for migraine sufferers.
Study Details
👥 Research Team: Birlea M et al.
📚 Published In: Curr Pain Headache Rep
📅 Publication Date: 2025 Nov 27
⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.